Treatment of Periodontal Disease With Two Different Bioactive Gels for Home Oral Care
Home Oral Care With Biorepair Implant Bioactive Gel and Chlorhexidine Gel 1% for the Improvement of Inflammatory Epidemiological Indices in Periodontal Patients: a Split-mouth Randomised Clinical Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
This study is an open-label split-mouth study in which periodontal patients will be treated in order to obtain periodontal health. After non-surgical therapy and air-perio polishing, a periodontal in-situ gelling product (Biorepair Implant Bioactive gel) will be applied in periodontal pockets in two quadrants (Q1-Q3 or Q2-Q4) of the mouth of the participants. At the same time, pockets of the contralateral quadrant will be irrigated with chlorhexidine gel 1%. Patients will continue to use gels at home for the following 14 days and on the same quadrants. Professional ora hygiene session will be performed after 1, 3 and 6 months from the baseline. Patients are divided into two groups with inverted quadrants administration in order to evaluate the improvements of periodontal inflammation indices and to assess the efficacy of Biorepair Implant Bioactive gel compared to chlorhexidine 1% gel treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedStudy Start
First participant enrolled
March 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2021
CompletedNovember 8, 2021
October 1, 2021
7 months
February 22, 2021
October 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
BOP% - Bleeding on Probing %
Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PPD, detected on 6 sites. Percentage of sites with bleeding on probing determines the BOP%.
1, 3 and 6 months.
PPD - Probing Pocket Depth
Evaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus or periodontal pocket, evaluated at 6 sites.
1, 3 and 6 months.
R - Gingival recession
Evaluation (in mm) of the distance between the gingival margin and the amelo-cemental junction (JEC). It is the exposure of the root surface, following the apical migration of periodontal structure.
1, 3 and 6 months.
PCR% - Plaque Control Record
% assessment of the amount of plaque on dental surfaces; it is detected on 4 surfaces: distal, mesial, vestibular, lingual / palatal. The number of sites with plaque is divided by the total number of sites available in the mouth and multiplied by 100. Results indicate the index as a percentage.
1, 3 and 6 months.
Dental mobility (Miller, 1985)
It is classified using numerical values: 0\. Grade 0: oscillation within 0.2 mm; the teeth move naturally and there are no mobility problems; 1. Grade I: horizontal mobility of the tooth from 0.2 to 1 mm; 2. Grade II: horizontal mobility of the tooth from 1 to 2 mm; 3. Grado III: horizontal mobility equal to or greater than 3 mm or vertical mobility of the tooth.
1, 3 and 6 months.
Secondary Outcomes (1)
Comparison between biorepair gel and chlorhexidine 1% gel
1, 3 and 6 months.
Study Arms (2)
Biorepair Gel (Q1-Q3) and Chlorhexidine 1% gel (Q2-Q4)
ACTIVE COMPARATORThe patients receive Biorepair Gel application in quadrants Q1 and Q3, whereas they receive chlorhexidine 1% gel in quadrants Q2 and Q4.
Chlorhexidine 1% gel (Q1-Q3) and Biorepair Gel (Q2-Q4)
ACTIVE COMPARATORThe patients receive chlorhexidine 1% gel in quadrants Q1 and Q3, whereas they receive Biorepair Gel application in quadrants Q2 and Q4.
Interventions
Professional application of Biorepair Gel after Scaling and Root Planing and Air-Perio polishing (glycine powders).
Irrigation of periodontal pockets with Chlorhexidine 1.00% gel afterScaling and Root Planing and Air-Perio polishing (glycine powders).
Eligibility Criteria
You may qualify if:
- Presence of periodontal disease according to the recent 2017 classification (2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions):
- Severity from grade I onwards (grade I: clinical attachment loss of 1-2 mm, bone loss in the cervical third greater than 15%, no elements loss for periodontitis);
- Complexity from grade II onwards (grade II: maximum probing depth of 5 mm, bone loss mainly horizontally);
- Presence of bilateral periodontal probes, both to the right and to the left of the midline incisal line.
- Subjects who gave their written informed consent to take part of the study.
You may not qualify if:
- Patient with cardiac pacemaker
- Patients suffering from psychological, neurological or psychiatric disorders
- Pregnant or breastfeeding women
- Cancer patients undergoing therapy
- Patients taking bisphosphonates within the last 12 months
- Patients with low compliance or inconsistent motivation
- Drug or alcohol users
- Presence of periodontal probes exclusively on the right or left side compared to the midline incisal line
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
Pavia, Lombardy, 27100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Scribante, DDS, PhD.
University of Pavia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Resident, Principal Investigator
Study Record Dates
First Submitted
February 22, 2021
First Posted
March 4, 2021
Study Start
March 16, 2021
Primary Completion
October 10, 2021
Study Completion
October 15, 2021
Last Updated
November 8, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share
Data will be available upon motivated request to Principal Investigator